Embolx is changing how hard-to-reach tumors are treated

Embolx is a medical device company that has developed a novel solutions for Pressure-directed solution for arterial embolization, with FDA approval and CE Mark to deliver pressure-directed therapy for treating tumors, enlarged prostate and fibroids. The Embolx Sniper allows for easy navigation through small complex vascular structures providing enhanced reach to distal target sites. The Embolx Soldier, a high flow balloon occlusion microcatherer, allows for navigation through small complex vascular structures to reach distal target sites. Arterial embolization procedures with clinical outcomes include: Transarterial Embolization (TAE); Transarterial Chemoembolization (TACE); Radioembolization (Y-90); Arteriovenous Malformation (AVM); Prostate Artery Embolization (PAE); Gastrointestinal Bleeds; Renal Angiomyolipoma (AML); Uterine Fibroid Embolization (UFE)